Keywords:
External validation; model-informed precision dosing; pediatrics; population pharmacokinetics; vancomycin
Abstract:
Vancomycin is used to treat serious gram-positive infections in children; however, effective dosing information for those aged 3 months to 18 years is limited. We aimed to determine an optimized dosing strategy for this age group.